← Leaderboards
Matteo Ruggiu
St. John'S University
$1,175,482
Attributed
$1,175,482
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $495K · FY2016–24$500K$375K$250K$125K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,175,482 · 2
By mechanism
R15$1,175,482 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsProteinsLearningNervous System DisorderPhysiologyPlayExonsKnockout MiceLocationMusclePathologyCellsAlternative SplicingCareerBrainEpilepsyGenesGraduate StudentBiologyBiomedical ResearchMolecularMolecular BiologyCellular BiologyRna-Binding Proteins
Grant awards (4)
Alternative Splicing Modulates the Activity of CaV3.1, an Ion Channel Gene Involved in Spinocerebellar Ataxia, Epilepsy, and Autism Spectrum Disorders.$89,149
R15 · FY2024 · GM · contact PI
Alternative Splicing Modulates the Activity of CaV3.1. an Ion Channel Gene Involved in Spinocerebellar Ataxia, Epilepsy, and Autism Spectrum Disorders$99,333
R15 · FY2023 · GM · contact PI
Alternative Splicing Modulates the Activity of CaV3.1, an Ion Channel Gene Involved in Spinocerebellar Ataxia, Epilepsy, and Autism Spectrum Disorders.$492,000
R15 · FY2022 · GM · contact PI
Investigating the Mechanism Regulating Alternative Splicing of Neural Agin: A Novel Therapeutic Entry Point for Congenital Myasthenic Syndrome$495,000
R15 · FY2016 · GM · contact PI